Insider · CIK 0001747818
Devin Whittemore Smith
officer
Files at IOBT (IO Biotech, Inc.). First filing Dec 23, 2024, latest Dec 23, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$9,720 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | IO Biotech, Inc. | $9,720 12,000 shares | +243% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | IOBT IO Biotech, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +140,000 | $0.00 | $0 | 140,000 | Apr 4, 2025 |
| Dec 23, 2024 | IOBT IO Biotech, Inc. | POpen-market purchase Common Stock | +12,000 | $0.81 | $9,720 | 16,938 | Dec 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.